263398-16-9

Upstream product

• 358-23-6 trifluoromethylsulfonic anhydride 
• 29799-07-3 4-adamantylphenol 
• 768-95-6 1-adamanthanol 
• 108-95-2 phenol 
• 768-90-1 1-Adamantyl bromide 

Downstream Products

• 885324-88-9 1-[4-(3-hydroxy-3-methylbutyn-1-yl)phenyl]adamantane 

Relevant academic research and scientific papers

Synthesis process of adamantane triphenylamine

The invention provides a synthesis process of adamantane triphenylamine. The synthesis process comprises the following steps: 1) taking adamantanol and phenol, adding into a solvent, and reacting to obtain adamantane phenol; 2) adding adamantane phenol, trifluoromethanesulfonic anhydride and alkali salt into a solvent for reaction to obtain adamantane phenyl trifluoromethanesulfonate; (3) adding the 2-bromo-4-chloroaniline, phenylboronic acid, a catalyst and alkali salt into a solvent, and reacting to obtain 2-phenyl-4-chloroaniline; (4) adding the 2-phenyl-4-chloroaniline, bis (pinacolato) diboron, a catalyst and alkali salt into a solvent, and reacting to obtain 4-amino-3-phenylboronic ester; and 5) adding adamantane phenyl trifluoromethanesulfonate, 4-amino-3-phenylboronic ester, a catalyst and alkali salt into a solvent, and carrying out a reaction to obtain adamantane triphenylamine. According to the method, raw materials are easy to obtain, operation is easy, hundred-kilogram-level production is achieved, the obtained product is high in purity, and the liquid phase purity reaches 99.9% or above.

LIGHT EMITTING DIODE AND DISPLAY DEVICE INCLUDING THE SAME

A light emitting diode of an embodiment includes a first electrode, a hole transport region disposed on the first electrode, an emission layer disposed on the hole transport region, an electron transport region disposed on the emission layer, and a second

NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE

Novel compounds and organic light emitting devices are disclosed. The novel compound is represented by the following Chemical Formula 1, and when the novel compound is used as a material for a hole transport layer of an organic light emitting device, the

ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME

The present invention relates to an adamantane derivative compound and an organic light-emitting diode (OLED) including the same, and more particularly, to an adamantane derivative compound capable of being used in an OLED and an OLED having excellent pro

CYCLIC AZINE COMPOUND HAVING ADAMANTYL GROUP, PRODUCTION METHOD, AND ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING SAID COMPOUND AS CONSTITUENT

wherein Ad each independently represents a 1-adamantyl group, etc., p and q are each independently 0 or 1, Ar1 and Ar2 are each independently a single bond (but only when p is 1, or q is 1), or a pyridyl group which may be substituted by a phenyl group, e

5-Arylethynyl-2′-deoxyuridines, compounds active against HSV-1

Three new 5-arylethynyl-2′-deoxyuridines containing bulky aryls have been prepared and tested against HSV-1 in Vero cells. The introduction of a substituent in the phenyl group of an inactive compound, 5-phenylethynyl- 2′-deoxyuridine, leads to the appear

2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors

Compounds having the formulas below, where R is H, lower alkyl, or a pharmaceutically acceptable salt, and where R1represents i-propyl, t-butyl or n-butyl groups, have selective RXR retionoid agonist activity.

2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors

Compounds of Formula 1, Formula 2 or Formula 3 where X is O, S, or (CR1R1)n where n is 0, 1 or 2; Y is a bivalent radical having Formula 4 or Formula 5 where o is an integer from 1 to 4 or Y is a bivalent aryl or 5 or 6 membered heteroaryl radical having 1 to 3 heteroatoms selected from N, S and O, said aryl or heteroaryl groups being unsubstituted, or substituted with 1 to 3 C1-6 alkyl or with 1 to 3 C1-6 fluoroalkyl groups; and the remaining symbols have the meaning described in the specification, have RXR selective retinoid agonist-like activity.